Outcomes of Liver Transplantation Among Patients Diagnosed With Acute-on-Chronic Liver Failure: A Single-Center Experience
Transplantation Proceedings · 2025-10 · 57 (8) · 1568-1573
DOI: 10.1016/j.transproceed.2025.06.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2025-10. Verfasst von Yoshitaka Saegusa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure, Liver Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Acute-on-chronic liver failure (ACLF) describes the rapid deterioration of liver function triggered by factors including alcohol consumption, infection(s), and exacerbation(s) of chronic liver disease, and is characterized by a persistent "cytokine storm." While liver transplantation is the most effective treatment, comprehensive data regarding patient outcomes are limited. METHODS: Clinical data from 187 patients, who underwent liver transplantation (excluding re-transplantations and acute liver failure) between 2009 and 2023, were analyzed in accordance with Japan's ACLF diagnostic criteria. Immunological analysis included a mixed lymphocyte reaction with carboxyfluorescein succinimidyl ester staining (CFSE-MLR). RESULTS: Among 171 patients, 13 had ACLF (grade 0, n = 6; grade 2, n = 5; grade 3, n = 2), and 158 had non-ACLF. Five-year survival rates for the ACLF and non-ACLF groups were similar regardless of ACLF severity. Patients with ACLF had higher preoperative Model for End-stage Liver Disease (ie, "MELD") scores and Child-Pugh scores, and higher rates of dialysis, renal dysfunction, and respiratory failure (P < .05). The graft rejection rate was higher in the ACLF group than that in the non-ACLF group, and the CFSE-MLR assay revealed significantly elevated CD8-positive T cell responses to donor antigens in the first week post-transplantation. CONCLUSION: Patients with ACLF achieved favorable postoperative outcomes despite poor preoperative conditions. High mortality rates among patients with ACLF on transplant waitlists emphasize the importance of timely transplantation. The increased anti-donor immune response after transplantation suggests a role for the underlying cytokine storm and underscores the need for careful postoperative management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
- Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; Medical Center for Translational and Clinical Research Hiroshima Unive…
Zitieren
APA
Saegusa, Y., Ohira, M., Honmyo, N., Nakano, R., Sakai, H., Shimizu, S., Kuroda, S., Tahara, H., Ide, K., Kobayashi, T., Tanaka, Y., & Ohdan, H. (2025). Outcomes of Liver Transplantation Among Patients Diagnosed With Acute-on-Chronic Liver Failure: A Single-Center Experience. Transplantation Proceedings, 57(8), 1568-1573. https://doi.org/10.1016/j.transproceed.2025.06.015
Vancouver
Saegusa Y, Ohira M, Honmyo N, Nakano R, Sakai H, Shimizu S, et al. Outcomes of Liver Transplantation Among Patients Diagnosed With Acute-on-Chronic Liver Failure: A Single-Center Experience. Transplantation Proceedings. 2025;57(8):1568-1573. doi:10.1016/j.transproceed.2025.06.015
BibTeX
@article{Saegusa2025,
author = {Saegusa, Yoshitaka and Ohira, Masahiro and Honmyo, Naruhiko and Nakano, Ryosuke and Sakai, Hiroshi and Shimizu, Seiichi and Kuroda, Shintaro and Tahara, Hiroyuki and Ide, Kentaro and Kobayashi, Tsuyoshi and Tanaka, Yuka and Ohdan, Hideki},
title = {Outcomes of Liver Transplantation Among Patients Diagnosed With Acute-on-Chronic Liver Failure: A Single-Center Experience},
journal = {Transplantation Proceedings},
year = {2025},
volume = {57},
number = {8},
pages = {1568--1573},
doi = {10.1016/j.transproceed.2025.06.015}
}
EUVIMED